Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Prostatic Neoplasms 4 Neoplasms 3 Colorectal Neoplasms 3 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Breast Neoplasms 2 Sarcoma 1 Rectal Neoplasms 1 Pancreatic Cancer Resectable 1 Lymphangioleiomyomatosis 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Gliosarcoma 1 Glioblastoma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 COVID-19 1 Breast Neoplasms, Male 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1 Arthritis, Rheumatoid 1 Anatomic Stage I Breast Cancer AJCC v8 1 Adenocarcinoma of Lung 1

Interventions

Sirolimus 5 Everolimus 4 carbon-11 acetate 1 Sugars 1 Simvastatin 1 Resveratrol 1 Octreotide 1 Letrozole 1 Imatinib Mesylate 1 Hydroxychloroquine 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Lymphangioleiomyomatosis × Hydroxychloroquine × Clear all

NCT01687179 2018-10-11

SAIL

Brigham and Women's Hospital

Phase 1 Completed

14 enrolled 14 charts

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡